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Abstract
The international Trial to Reduce IDDM in the Genetically at Risk (TRIGR) tested the
hypothesis whether extensively hydrolyzed casein-based versus regular cow's milk-
based infant formula reduces the risk of type 1 diabetes. We describe dietary compliance in the trial in terms of study formula intake, feeding of nonrecommended foods,
and serum cow's milk antibody concentration reflecting intake of cow's milk protein
among 2,159 eligible newborn infants with a biological first-degree relative affected

Deceased.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2021 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC
Food Sci Nutr. 2021;9:4221–4231.	

www.foodscience-nutrition.com

|

4221

4222

|

and Human Development and the Special
Statutory Funding Program for Type
1 Diabetes Research administered by
the National Institute of Diabetes and
Digestive and Kidney Diseases, National
Institutes of Health (The content is
solely the responsibility of the authors
and does not necessarily represent the
official views of the National Institutes
of Health), Canadian Institutes of Health
Research, the Juvenile Diabetes Research
Foundation International, the Commission
of the European Communities (specific
RTD programme “Quality of Life and
management of Living Resources”, contract
number QLK1-2002-0 0372 "Diabetes
Prevention." It does not reflect its views
and in no way anticipates the Commission's
future policy in this area.) and the EFSD/
JDRF/Novo Nordisk Focused Research
Grant. The study formulas were provided
free of charge by Mead Johnson Nutrition

VIRTANEN et al.

by type 1 diabetes and with HLA-conferred susceptibility to type 1 diabetes. The
participating infants were introduced to the study formula feeding at the median age
of 15 days with a median duration of study formula use of 63 days. During the intervention, 80% of the infants received study formula. Of these, 57% received study
formula for at least 2 months. On average, 45.5 l of study formula were used per infant. Only 13% of the population had received a nonrecommended food by the age of
6 months. The dietary compliance was similar in the intervention and control arm. The
reported cow's milk consumption by the families matched very well with measured
serum casein IgA and IgG antibody concentration. To conclude, good compliance was
observed in this randomized infant feeding trial. Compliance varied between the regions and those infants who were breastfed for a longer period of time had a shorter
exposure to the study formula. High dietary compliance in infant feeding trial is necessary to allow accurate interpretation of study results.
KEYWORDS

infant and child nutrition, infant feeding, infant formula, nutritional interventions, randomized
controlled trial, research methodology, type 1 diabetes

1 | I NTRO D U C TI O N
Type 1 diabetes is one of the most common chronic diseases of
childhood with an increasing incidence around the world (Patterson
et al., 2019). The etiology is complex and involves a genetic predisposition with suspected environmental triggers associated with
autoimmune destruction of insulin-producing beta cells (Virtanen
& Knip, 2003). Certain dietary factors, along with viral infections,
are among the main suspects in the etiology of type 1 diabetes
(Virtanen, 2016). Of the dietary factors, early feeding of cow's
milk proteins has received much research attention with inconsistent evidence from both prospective cohorts and randomized trials
(Hummel et al., 2017; Knip et al., 2010, 2014; Vaarala et al., 2012;
Virtanen, 2016; Writing Group for the TRIGR Study Group
et al., 2018). Human studies are mostly observational and therefore
confounded by issues such as breastfeeding rates and choices and

Key messages
• In the TRIGR study, the intervention was designed to
study 2 separate groups of infants—one exposed to
cow's milk protein and a nonexposed group in order to
assess the effect on rates of diabetes autoimmunity and
diabetes.
• Good dietary compliance was observed in this international randomized infant feeding trial whether measured by exposure to the study formulas, exposure to
nonrecommended foods or by serum cow's milk protein
antibodies.
• Compliance varied between the regions and those infants who received longer breastfeeding had a shorter
exposure to the study formula.

selection bias. The Trial to Reduce IDDM in the Genetically at Risk
(TRIGR) study reported that the cumulative incidence of diabetes-
associated autoantibodies and type 1 diabetes in children with a

prevention of type 1 diabetes. In this study, dairy foods were also

first-degree relative with type 1 diabetes and a risk-associated HLA

to be avoided in the intervention period. Compliance with a dietary

genotype did not differ in children weaned to an extensively hydro-

intervention and evaluation of variables associated with high com-

lyzed casein formula and one containing intact cow's milk proteins

pliance is essential factors to assess in a nutrition intervention trial.

(Writing Group for the TRIGR Study Group et al., 2018).

Excessive noncompliance can not only result in reduced statistical

TRIGR is a randomized controlled trial launched to determine

power to detect significant associations but also limit the ability to

whether weaning to extensively hydrolyzed infant formula com-

accurately interpret study results. In a pilot of the current study, very

pared to one containing intact cow's milk proteins given during the

good compliance was observed: A majority of the infants (84%) were

first 6–8 months of life would prevent type 1 diabetes in genetically

exposed to study formula for at least 2 months and the levels of

susceptible children (Knip et al., 2014; TRIGR Study Group, 2007;

cow's milk protein antibodies reflected very well cow's milk protein

Åkerblom et al., 2011; Writing Group for the TRIGR Study Group

intake (Virtanen et al., 2011; Yang et al., 2016) examined compliance

et al., 2018). It is the first nutritional full-scale randomized trial for

with the completion of food records in a large cohort of children in

|
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The Environmental Determinants of Diabetes in the Young (TEDDY)

(e.g., religious, cultural, and unwillingness) to refuse feeding the in-

study. Factors associated with high compliance included older ma-

fant with cow's milk-based products were excluded including those

ternal age and higher maternal education while poor compliance was

who planned only to breastfeed without ever using formula (TRIGR

observed in families who lived far from the study centers and were

Study Group, 2007). Recruitment and retention strategies have been

from ethnic minority groups (Yang et al., 2016).

described in detail previously (Franciscus et al., 2014). Written in-

In the current study, we evaluate the degree of compliance to

formed consent was collected from all families, signed by the legal

the use of study formula and to the dietary instructions on recom-

guardian of the child. The study was approved by the ethics commit-

mended and nonrecommended foods. In addition, we assess how

tees of all participating centers and was conducted according to the

the reported compliance is associated with the one measured by

standards of the Declaration of Helsinki and conforms to Directive

cow's milk protein antibodies. Also factors associated with the re-

2010/63/EU.

ported compliance are assessed.

2 | M E TH O DS
2.1 | Recruitment and randomization

2.2 | Dietary intervention
Breastfeeding was encouraged. Infants were randomized to receive either an extensively hydrolyzed casein-based infant formula (Nutramigen®) or a regular cow's milk-based infant formula

Newborn infants with a biological first-degree relative (mother, fa-

upon weaning from breast milk or when supplemental feeding was

ther, or full sibling) affected by type 1 diabetes as defined by the

needed in a double-blind fashion. Both study formulas were nutri-

World Health Organization were invited to participate. Recruitment

tionally complete infant formulas in powder form manufactured by

strategies have been previously described in detail (TRIGR Study

one company and provided to families free of charge (Mead Johnson

Group, 2007). The families were recruited when the mother was in

Nutritionals). The control formula was a mixture of commercial regu-

late pregnancy (gestational age 35 weeks or more) or within 7 days

lar cow's milk-based formula powder plus casein hydrolysate powder

of delivery. Informed consent was signed by the parents or legal

in a 4:1 ratio in order to mask the flavor and smell differences be-

guardians of the infant. Human leukocyte antigen (HLA) genotyping

tween the formulas. Formula was packaged in four different colors:

was performed from cord blood or from a blood sample obtained

two for test and two for control formula to aid in the blinding pro-

before the age of 8 days. Infants with increased HLA-conferred

cess, to provide a control for randomization during data analysis, and

susceptibility to type 1 diabetes were eligible to participate (TRIGR

help to avoid accidental mis-shipments as the families recognized

Study Group, 2007). Altogether 2,159 infants from 12 countries in

their formula can color. Nutramigen® or banked breast milk was used

Europe and from United States, Canada, and Australia born between

if feeding other than breast milk was needed prior to randomization

May 2002 and February 2007 were included in the TRIGR study

or in delivery hospitals if study formula was unavailable in order to

(Åkerblom et al., 2011). Of these infants, 1,095 were born to women

avoid exposure to intact cow's milk proteins.

with type 1 diabetes.

The intervention lasted until the infant was 6 months old or

Randomization stratified by geographic area was implemented

if he/she had not received study formula at least for 2 months at

after 35 weeks of gestation or immediately after birth by the TRIGR

that time until the age of 7–8 months. Families were counseled to

data management unit via the TRIGR website. The TRIGR countries

avoid all other infant formulas and food products containing cow's

were divided into seven regions, Northern Europe (Estonia, Finland,

milk or beef. Nutramigen® was given to infants with suspected or

and Sweden, n = 555), Central Europe I (Czech Republic, Hungary and

proven cow's milk allergy. The use of any other infant formula (e.g.,

Poland, n = 281) (transition economies), Central Europe II (Germany,

soy-based ones) was discouraged, to maximize exposure to study

Luxembourg, the Netherlands and Switzerland, n = 186), Southern

formula.

Europe (Italy and Spain, n = 114), the United States (n = 394), Canada

During the intervention phase, four study monitors managed in-

(n = 528), and Australia (n = 101). The early randomization allowed

ternational coordination between European countries and Australia,

immediate use of study formula if breastmilk was not available. If

and within North America. Each country had at least one coordi-

supplemental feeding was needed prior to randomization either

nator and in case of several study centers, also a local coordinator

banked breastmilk or Nutramigen® was given. Ethical approval was

in each center. Each study center had nurses and physicians with

obtained at each study center.

experience in pediatrics, diabetes, neonatology or obstetrics, labo-

Exclusion criteria included multiple gestation, an older sibling al-

ratory technicians, and during the intervention period, dietitians. In

ready participating in TRIGR, recognizable severe illness, gestational

each country, parents were provided lists of foods with brand names

age <35 weeks, age of the infant more than 7 days at randomization,

that did not contain cow's milk protein and could be used during the

and no HLA sample drawn before the age of 8 days. Those infants

intervention as well as lists of nonrecommended foods containing

who had received any infant formula other than the study formula

dairy protein. Dietary advice leaflets, manual of operations, dietary

or Nutramigen® (Mead Johnson Nutritionals) prior to randomiza-

interview forms, and other questionnaires were translated into 11

tion, were also excluded. Finally, families having any other reasons

languages and adapted to national practices.

4224
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Information on infant feeding was acquired from the family

was days and did not differ between the arms. According to dietary

through standardized dietary interviews. Data on the frequency of

reports on average 45.5 L of study, formula were used per child. The

use of several allowed and nonrecommended foods were collected

amount of study formula used was smaller in the casein hydrolysate

with a validated (Vahatalo et al., 2006) food frequency questionnaire

than control arm (p =.012). At 6 months of age, fewer than 4% of

at several time points during the first year of life. Mothers were ad-

infants were being exclusively breastfed.

vised and interviewed by a dietitian/study nurse by telephone when

During the first 3 days of life, 57.8% of the infants were exclu-

the child was 2 weeks old, 1, 2, 4, and 5 months old, and by a study di-

sively breastfed, 8.9% had received banked milk only, 3.5% had re-

etitian during the visits at the age of 3, 6, and 9 months. When study

ceived study formula only, 15.1% had received Nutramigen® only,

formula feeding continued after the age of 6 months, 7 and 8 month

0.5% had received nonrecommended infant formula only, 13.7% had

telephone interviews were conducted by the dietitian/study nurse.

received two or more types of feeding, and 0.5% were reported not

Study formula exposure was defined as any reported consumption

to have received any oral feeding. Of those who had received sev-

of study formula. If the child had not received the study formula for

eral feeding types (n = 290), 2.2% had received nonrecommended

at least 60 days by 6 months of age, the intervention continued until

infant formula. As study formula feeding was not available at all the

60 days of study formula exposure was obtained up to a maximum of

delivery hospitals, Nutramigen® was considered allowed feeding

8 months of age. Noncompliance was defined as any reported expo-

straight after delivery. The early feeding did not differ between the

sure to nonapproved formula (anything but assigned study formula

treatment arms.

or Nutramigen®) or nonrecommended foods (any foods containing
milk or beef proteins).

There was considerable variation in study formula use between
the regions ranging from a low of 75% in North America to 86% in
Australia and Northern Europe (Table 1). There was some increase in

2.3 | Measurement of cow's milk protein antibodies

the use of study formula by time: the proportion of infants who received it for at least 2 months increased and the proportion of nonusers decreased by time (Appendix S1). The use of nonrecommended

IgA and IgG antibodies to cow's milk formula, beta-lactoglobulin and

foods: cow's milk-based infant formulas and other foods containing

alpha-casein, were measured from serum samples obtained from

cow's milk or beef was similar in the treatment arms (Appendix S2).

cord blood and at the age of 3 and 6 months by ELISA (Savilahti

By the age of 6 months, 13% and 12% of the participating children in

et al., 1993). Cow's milk formula IgA and IgG antibodies at the age of

the intervention and control arm, respectively, had been exposed to

0, 3, 6, and 9 months are presented in the current article to show the

nonrecommended foods.

levels in the treatment arms and by cow's milk exposure.

2.4 | Statistical methods

3.2 | Exposure to nonrecommended
formula and foods

The change in IgA and IgG casein antibody levels from 6 to 9 months

Exposure to Nutramigen® was mostly restricted to the infants

of age was calculated by paired t test. Factors associated with the use

with proven or suspected study formula intolerance (data not

of study formula were analyzed by conditional logistic regression.

shown). The only exception was when Nutramigen® was given at
the delivery hospital when breast milk or study formula was not

3 | R E S U LT S

available. Study formula intolerance was equally often suspected
among children in the casein hydrolysate and control arms (data
not shown). The cumulative incidence by the age of 6 months was

Among the infants of the 5,156 randomized mothers, 2,159 were

in Central European countries I 1.4%, Southern European coun-

eligible (Figure 1). Drop-out from the study during the intervention

tries 1.9%, Central European countries II 2.2%, Northern European

period was small and similar in both intervention arms (control arm,

countries 3.8%, Canada 6.7%, Australia 7.0%, and in the United

n = 18; casein hydrolysate, n = 27).

States 11.2%.
In the casein hydrolysate arm, 80.0% used the study formula

3.1 | Rates and duration of exposure to assigned
study formula

during the intervention (Table 1) and most infants were reported
to be unexposed to bovine protein at all the visits/calls (Figure 2a).
Exposure to cow's milk proteins varied from 2.1% at 1 month of age
to 8.2% at 6 months, being 15.3% at 8 months for those participants

By the end of the intervention period, 80.4% of infants had received

who were still in intervention at that time. Cumulatively 84.0% were

study formula and 56.7% for at least 2 months (Table 1). This did

not exposed to foods containing bovine protein by 6 months of age

not differ between the intervention and control arms at 80.0% and

and 81.1% by the end of the intervention.

80.8%, respectively. The median age at introduction of study for-

In the control arm, 80.8% were exposed to study formula during

mula was 15 days, and the median duration of study formula use

the intervention (Table 1). The proportion of infants exposed to

|
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F I G U R E 1 Flow chart of the trial to
reduce IDDM in genetically at risk

Registered Mothers
N=5606

Randomized
N=5156

No Consent for
Randomizaon

4225

N=450

Parcipant Ineligible
N=156
Parcipant HLA not eligible N=2841

HLA Eligible
N=2159
Control Formula
N=1081

Casein Hydrolysate
N=1078

Drop-outs

N=2

2 week visit
N=1077

2 week visit
N=1075

Drop-outs

N=3

Drop-outs

N=1

1 mos visit
N=1073

1 mos visit
N=1071

Drop-outs

N=2

Drop-outs

N=1

2 mos visit
N=1071

2 mos visit
N=1070

Drop-outs

N=1

Drop-outs

N=7

3 mos visit
N=1064

3 mos visit
N=1063

Drop-outs

N=4

Drop-outs

N=3

4 mos visit
N=1059

4 mos visit
N=1058

Drop-outs

N=3

Drop-outs

N=1

5 mos visit
N=1058

5 mos visit
N=1057

Drop-outs

N=0

Drop-outs

N=1

6 mos visit
N=1056

6 mos visit
N=1054

Drop-outs

N=2

Drop-outs
N=2
Refused Samples N=2

9 mos visit
N=1052

9 mos visit
N=1040

Drop-outs
N=12
Refused Samples N=2

bovine protein either in the form of study formula or nonrecom-

4 | D I S CU S S I O N

mended foods varied from 42.9% during the first 2 weeks to 64.3%
during the 6th month of life (Figure 2b). Cumulatively, 77.2% were

In the TRIGR study, the intervention was designed to study 2 sepa-

exposed to bovine protein by 6 months of life and 86.7% by the end

rate groups of infants—one exposed to cow's milk protein and a

of the intervention.

nonexposed group in order to assess the effect on rates of diabe-

Median cow's milk IgA and IgG antibody concentrations by age,

tes autoimmunity and diabetes. Implementing a dietary intervention

intervention arm, and cow's milk exposure are shown in Figure 3.

that is maintained over 6–8 months when the dietary component

Cow's milk IgA and IgG concentrations increased from birth among

of interest (cow's milk protein) is very common is challenging. This

those control arm children with reported cow's milk exposure

report shows that such an intervention can be maintained with rela-

(Figure 3a,b). From 6 to 9 months, the levels of cow's milk IgA and

tively good success. There are two main areas of interest in an inter-

IgG increased in all groups (p < .001).

vention such as this. The first is cooperation in use of and exposure

Fifty-seven percent of the infants were exposed to study for-

to the randomized study formula for sufficient duration. The second

mula for at least 2 months. Of the different sociodemographic and

issue is compliance to the list of nonapproved formulae and foods.

clinical factors studied only country and duration of breastfeeding

In our study, these exposures were low but increased with age of

were associated with at least 2 months of use of study formula in

the infant. We have shown that good success can be obtained in a

the model adjusted additionally for maternal age, education and

complex dietary intervention such as this.

type 1 diabetes, and sex of the child (Table 2). Being from Southern

Cooperation in use of the study formula, after breastfeed-

European countries, Canada and the United States compared to

ing, was high at 80.4% with 56.7% using study formula for at least

Northern European countries and being breastfed at least 6 months

2 months by the end of the intervention. The intervention and con-

were associated with less compliance with at least 2 months study

trol arms were similar regarding study formula use. The only excep-

formula use (Table 2).

tion was the slightly lower reported amount of study formula used

4226
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TA B L E 1 Study formula (SF) use by region: proportion of users, median (interquartile range, IQ) age at introduction and duration of use
and mean amount of reported amount of study formula used

Regiona

HLA eligible
randomized

SF users

N

N

Age at SF
introduction (days)

SF duration (days)

Amount of
SF used (l)

%

Median

IQ range

Median

IQ range

Mean

SF use >2 months
%

N

Australia

101

87

86.1

70

69.3

49

8–168

63

42–112

40.2

Canada

528

399

75.6

287

54.4

16

5–63

63

2–161

55.9

Central Europe I

281

236

84.0

170

60.5

31

4–168

63

21–119

40.7

Central Europe II

186

147

79.0

111

59.7

35

11–168

63

7–140

45.4

Northern Europe

555

481

86.7

332

59.8

8

3–8 4

63

21–126

35.4

Southern Europe

114

91

79.8

60

52.6

10

3–105

67

2–154

50.3

United States

394

295

74.9

194

49.2

16

6–60

56

2–154

49.2

Hydrolysate arm

1,081

865

80.0

595

55.0

16

4–112

63

2–126

42.3

Control arm

1,078

871

80.8

629

58.4

15

4–8 4

63

7–154

48.7

All

2,159

1,736

80.4

1,224

56.7

15

4–98

63

7–147

45.5

a

Central Europe I includes Czech Republic, Hungary, and Poland; Central Europe II includes Germany, Luxembourg, Netherlands, and Switzerland;
Northern Europe includes Estonia, Finland, and Sweden; and Southern Europe includes Italy and Spain.

by the intervention than control arm participants. In the current

formulas have varied between 16% and 30% (Kalliomaki et al., 2001;

study, extensively hydrolyzed infant formula was used as the inter-

Makrides et al., 1999; Mallet & Henocq, 1992; Marini et al., 1996;

vention tool to avoid exposure to intact cow's milk proteins. The cu-

Zeiger et al., 1989). In infant feeding trials, relatively good dietary

mulative proportion of infants not exposed to cow's milk proteins

compliance has been observed. In a Danish allergy avoidance study,

was 81% in the hydrolysate arm and the cumulative proportion of

6.2% of the 550 infants received another formula than originally

infants exposed to it was 81% in the control arm. This contrast in

randomized to (Halken et al., 2000). In a Swiss allergy prevention

the exposures can be considered relatively good. Our measurement

study, dietary noncompliance rate was 8.4% including the use of

of antibodies to supplement the dietary interviews shows that the

other infant formulas and weaning foods than recommended (Exl

information reported by the families appeared to be reliable given

et al., 2000). In a German study on allergy prevention, of the 2,252

that the reported cow's milk consumption was consistent with the

infants randomized to one of the four formulas, 58% received the

measured casein IgA and IgG antibody concentration in serum.

study formula and 11% made deviations in the advised diet (von Berg

Breastfeeding for at least 6 months and being from Southern Europe

et al., 2003). In another German study, Schoetzau et al. (2002) ex-

or North America were associated with lower rates of exposure to

amined maternal compliance with nutritional recommendations in an

study formula for at least 2 months.

allergy prevention trial and reported factors that influenced compli-

In the hydrolysate study formula arm, unintended exposure to

ance. The intervention was similar to the TRIGR trial in that families

cow's milk proteins was very low: varying from 2% at 1 month of age

were advised to use the study formula if breastfeeding was not pos-

to 8% at 6 months, and being 15% at 8 months for those participants

sible and to avoid the introduction of solid foods before 4 months

who were still in the intervention. Exposure to nonapproved formula

of age. The authors reported a drop-out rate of 13.5% during the

and foods was similarly low in the control arm (0% at 1 month, 2%

first year of life and a high compliance (defined as completion of all

at 6 months, and 8% at 8 months). The dietary interview forms used

infant diaries and adherence to all nutritional recommendations) rate

were validated (Vahatalo et al., 2006) and translated into all the lan-

of 83.4% between weeks 1 and 16. In comparison, the TRIGR study

guages of the study countries making it likely that data collected re-

observed a 3% drop-out rate at 1 year and had an 80.4% compliance

garding noncompliance is complete.

rate at the completion of the intervention.

The drop-out rates by the age of 2 years in infant feeding trials using

Compared to the previous TRIGR pilot study, a smaller proportion

hydrolyzed and long-chain polyunsaturated fatty acid-containing

of the infants received study formula, for example, the proportion

F I G U R E 2 (a) Hydrolysate arm: the proportion (%) of children by type of feeding at the time of each interview. All of the categories may
include breast milk. All of the children followed for at least 6 months are included (N = 1,054). The 7 and 8 month interview included only
children who continued in the intervention up to that time: 558 and 498 children, respectively. (b) Control arm: the proportion (%) of children
by type of feeding at the time of each interview. All the categories may include breast milk. All the children followed up at least for 6 months
are included (N = 1,056). The 7 and 8 month interview included only children who continued in the intervention up to that time: 512 and 446
children, respectively

VIRTANEN et al.
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of infants with at least 2 months study formula exposure was 57%

the recommended diet by giving cow's milk-based infant formulas

in the current study compared to 84% in the pilot study (Virtanen

other than the study formula and/or other nonrecommended foods

et al., 2011). In the current study, the introduction of study formula

containing cow's milk or beef were similarly moderate in the current

happened earlier (median 2 weeks of age compared to 2 months

and pilot studies (18% in both).

in the pilot) and the duration of observed study formula use was

There are a number of factors in this study that may have led to

shorter (median 2 months versus 4 months, respectively). The dif-

this degree of success in maintaining separation between the study

ference in the length of the study formula use between the studies

arms. The study had a rigorous double-blind randomized trial design.

was partly explained by the fact that longer than recommended use

Blinding was facilitated by the addition of 20% of casein hydroly-

of study formula was rather common in the pilot study, 33% of the

sate also to the control formula, so the study formulas could not be

infants receiving study formula longer than recommended (Virtanen

differentiated by taste or smell. The families were contacted fre-

et al., 2011). The reported proportion of families who deviated from

quently during the intervention and the drop-out up was small. The

F I G U R E 3 Median levels of (a) cow's
milk IgA antibodies and (b) cow's milk IgG
antibodies by age, intervention arm, and
cow's milk (CM) exposure status
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TA B L E 2 Sociodemographic and
clinical factors associated with compliance
with at least 2 months use of study
formula. Odds ratios (95% CI) for
significant associations (p <.05) are bolded

Odds
ratio

95% CI

Adjusted odds
ratioa

95% CI
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b

Regions versus. Northern Europe:
Central Europe I

1.03

0.77–1.39

0.99

0.69–1.43

Central Europe II

1.02

0.73–1.43

0.95

0.70–1.31

Southern Europe

0.75

0.50–1.12

0.59

0.38–0.92

Australia

1.52

0.97–2.40

1.60

0.99–2.59

Canada

0.81

0.63–1.03

0.72

0.56–0.93

United States

0.65

0.50–0.85

0.60

0.45–0.80

Maternal age, years

0.97

0.95–0.99

0.99

0.97–1.01

Maternal education,
years

0.93

0.91–0.96

0.99

0.96–1.02

Maternal type 1 diabetes

1.18

0.99–1.40

0.92

0.76–1.11

Sex of the child: boy
versus girl

1.15

0.97–1.37

1.14

0.95–1.37

Treatment: hydrolysate
versus control formula

0.88

0.74–1.04

1.10

0.92–1.32

Breastfeeding:
≥6 months versus. less

0.25

0.21–0.31

0.25

0.20–0.30

a

The logistic regression model includes all the variables in the table.

b

All the regions were included at the same time in the logistic regression analysis, Northern Europe
(Estonia, Finland, and Sweden) was used as reference. Central Europe I consists of Czech Republic,
Hungary, and Poland), Central Europe II of Germany, Luxembourg, Netherlands, and Switzerland,
and Southern Europe of Italy and Spain.

availability of national and international coordinators (some of them

In the TRIGR pilot study, the use of extensively hydrolyzed in-

nutritionists) and dietitians, helped to maintain regular training of

fant formula decreased the incidence of islet cell autoantibodies,

the personnel, coordination of the training between the regions and

whereas in the current study no effect on islet autoimmunity was

rapid responses to queries from the sites (Franciscus et al., 2014). A

seen (Knip et al., 2010, 2014). The earlier and smaller exposure to

manual of operations contained detailed description of study proce-

study formulas in the current than in the pilot study needs to be

dures including recruitment, training, advising of the families, advice

considered as one possible explanation when interpreting the incon-

material, forms, and study conduct. We have shown earlier that the

sistent findings of the two studies.

intervention did not adversely affect breastfeeding habits (Sorkio

To conclude, good dietary compliance was observed in an inter-

et al., 2010). It could also be that the families who knew the child's

national randomized infant feeding trial whether measured by ex-

HLA risk invested in the study demands.

posure to the study formulas, exposure to nonrecommended foods

This study has several limitations. Although our retention rates

or by cow's milk protein antibodies. Compliance varied between the

exceeded planning parameters and the amount of missing infor-

regions and those infants who received longer breastfeeding had a

mation was very low, there is the possibility that participation in

shorter exposure to the study formula.

a nutrition intervention trial influenced families’ feeding choices.
Compliance rates may also have been influenced by confounding
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